Imperial College London Featured PhD Programmes
University of Sheffield Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Sheffield Featured PhD Programmes

The functional characterization of the tumour suppressor gene CSMD1 in breast cancer

  • Full or part time
  • Application Deadline
    Applications accepted all year round
  • Self-Funded PhD Students Only
    Self-Funded PhD Students Only

Project Description

CUB and Sushi multiple domains protein 1 (CSMD1) maps to 8p23, a region deleted in many cancers including breast cancer. Our previous work has established that CSMD1 is an independent prognostic marker in ductal breast cancer, with reduced expression associated with high tumour grade and poor survival1. CSMD1’s function is unknown; however, our data suggests that CSMD1 is involved in a signaling cascade regulating a wide range of cell processes involved in cancer development.

We have already generated shRNA and CRISPR cell lines with reduced CSMD1 expression to investigate the function of CSMD1. Analysis of these cell lines has shown that suppression of CSMD1 expression disrupts cell morphology, in an effect resembling the epithelial-mesenchymal transition (EMT), increases cell proliferation, and enhances cell migration and cell invasion2. We have also established an MCF10A three-dimensional culture model with reduced CSMD1 expression which revealed that loss of CSMD1 expression resulted in the development of larger and more poorly differentiated breast ductal structures2. In addition, we have also recently developed an in vivo model with reduced CSMD1 expression. Our aims will be to investigate the role of CSMD1 in metastasis which is the primary cause of cancer-associated mortality. We will study the mechanisms behind the function of CSMD1 in EMT, tumour migration and invasion using our 3D culture and in vivo models.

You will gain experience of a broad range of molecular and cell biology laboratory techniques including CRISPR, cell culture of 3D models, confocal microscopy, live cell imaging, Gene expression analysis, RT-PCR, pathway analysis, Western blotting, in vivo work, migration and cell invasion assays, immunohistochemistry and immunofluorescence.

Eligibility
You should hold a strong first degree equivalent to at least a UK upper second class honours degree in a relevant subject.

The Faculty minimum requirements for candidates whose first language is not English are:

• British Council IELTS - score of 6.5 overall, with no element less than 6.0
• TOEFL iBT - overall score of 92 with the listening and reading element no less than 21, writing element no less than 22 and the speaking element no less than 23.

How to Apply

To apply for this scholarship applicants should complete a Faculty Scholarship Application form using the link below https://medicinehealth.leeds.ac.uk/downloads/download/129/faculty_graduate_school_-_application_form and send this alongside a full academic CV, degree certificates and transcripts (or marks so far if still studying) to the Faculty Graduate School

We also require 2 academic references to support your application. Please ask your referees to send these references on your behalf, directly to

If you have already applied for other scholarships using the Faculty Scholarship Application form for this academic year you do not need to complete the form again. Instead you should email to inform us you would like to be considered for this scholarship project.

Any queries regarding the application process should be directed to

Funding Notes

This project is available for self funded applicants only.

References

1. Kamal M, Shaaban AM, Zhang L, Walker C, Gray S, Thakker N, Toomes C, Speirs V, Bell SM. Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma. Breast Cancer Res Treat (2010) 121(3):555-63.
2. Kamal M, Holliday DL, Morrison EE, Speirs V, Toomes C, Bell SM. Loss of CSMD1 expression disrupts mammary duct formation while enhancing proliferation, migration and invasion. Oncology Reports (2017) Jul;38(1):283-292.

Email Now

Insert previous message below for editing? 
You haven’t included a message. Providing a specific message means universities will take your enquiry more seriously and helps them provide the information you need.
Why not add a message here
* required field
Send a copy to me for my own records.

Your enquiry has been emailed successfully





FindAPhD. Copyright 2005-2019
All rights reserved.